➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Express Scripts
McKesson
Medtronic
Baxter

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

NATESTO Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Natesto, and when can generic versions of Natesto launch?

Natesto is a drug marketed by Acerus and is included in one NDA. There are four patents protecting this drug.

This drug has twenty-seven patent family members in twenty-one countries.

The generic ingredient in NATESTO is testosterone. There are sixty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Natesto

A generic version of NATESTO was approved as testosterone by ACTAVIS LABS UT INC on January 27th, 2006.

  Try it Free

Summary for NATESTO
Drug patent expirations by year for NATESTO
Drug Prices for NATESTO

See drug prices for NATESTO

Recent Clinical Trials for NATESTO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Baylor College of MedicineEarly Phase 1
University of MiamiPhase 4
Acerus Pharmaceuticals CorporationPhase 4

See all NATESTO clinical trials

Pharmacology for NATESTO
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for NATESTO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX No No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX No No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX No No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Express Scripts
McKesson
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.